Sale!

Sickle Cell Disease Mutation Screening

Original price was: $176.Current price is: $132.

-25%

Sickle Cell Disease Mutation Screening is a specialized genetic test that identifies mutations in the HBB gene responsible for sickle cell anemia. This comprehensive screening detects the specific genetic variations that cause abnormal hemoglobin production, leading to sickle-shaped red blood cells. The test is crucial for individuals with family history of sickle cell disease, couples planning pregnancy, and those experiencing symptoms like chronic pain, anemia, or frequent infections. Using advanced End Point PCR technology, this screening provides definitive results within 3-4 days from a simple blood sample. Early detection through this $132 USD test enables proactive management, genetic counseling, and informed family planning decisions. Our nationwide network ensures convenient access across all major US cities.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

Sickle Cell Disease Mutation Screening

Comprehensive Genetic Testing for Sickle Cell Anemia

Sickle Cell Disease Mutation Screening represents a critical advancement in genetic diagnostics, providing definitive identification of mutations in the HBB gene that cause sickle cell anemia. This inherited blood disorder affects millions worldwide and requires precise genetic analysis for accurate diagnosis and management. Our state-of-the-art screening utilizes cutting-edge molecular technology to deliver reliable results that guide clinical decisions and family planning strategies.

What This Test Measures and Detects

This specialized genetic screening targets specific mutations in the beta-globin gene (HBB) that lead to the production of abnormal hemoglobin S. The test precisely identifies:

  • Homozygous sickle cell disease (HbSS)
  • Sickle cell trait (HbAS)
  • Compound heterozygous conditions
  • Specific point mutations affecting hemoglobin structure
  • Genetic variants associated with disease severity

Using End Point PCR methodology, the test amplifies and analyzes DNA sequences to detect the exact genetic alterations responsible for sickle cell disorders, providing molecular-level confirmation beyond traditional hemoglobin electrophoresis.

Who Should Consider Sickle Cell Mutation Screening

This genetic screening is recommended for individuals experiencing:

  • Unexplained chronic pain episodes
  • Recurrent anemia or fatigue
  • Frequent infections or immune system concerns
  • Family history of sickle cell disease or trait
  • Couples planning pregnancy with ethnic backgrounds at higher risk
  • Individuals of African, Mediterranean, Middle Eastern, or Indian descent
  • Newborns with abnormal newborn screening results
  • Patients with unexplained organ damage or complications

Significant Benefits of Genetic Screening

Early detection through Sickle Cell Disease Mutation Screening offers numerous advantages:

  • Early Intervention: Enables proactive management before severe symptoms develop
  • Accurate Diagnosis: Provides definitive genetic confirmation beyond symptomatic assessment
  • Family Planning Guidance: Informs reproductive decisions and genetic counseling
  • Personalized Treatment: Guides targeted therapeutic approaches based on genetic profile
  • Risk Assessment: Identifies carrier status for informed family planning
  • Comprehensive Care: Facilitates multidisciplinary management strategies

Understanding Your Test Results

Your genetic screening results will fall into one of several categories, each with specific implications:

  • Normal Result: No sickle cell mutations detected – low risk for developing sickle cell disease
  • Sickle Cell Trait: One copy of the mutated gene – carrier status with no symptoms typically
  • Sickle Cell Disease: Two copies of mutated genes – requires comprehensive medical management
  • Compound Heterozygous: Combination with other hemoglobin variants – variable clinical presentation

Our genetic counselors provide detailed explanations of your results and discuss appropriate next steps, including specialist referrals, monitoring recommendations, and family testing considerations.

Test Pricing and Details

Test Component Details
Test Name Sickle Cell Disease Mutation Screening
Discount Price $132 USD
Regular Price $176 USD
Turnaround Time 3-4 days
Sample Type Peripheral Blood
Test Components EDTA Vacutainer (2 ml)
Testing Method End Point PCR

Nationwide Accessibility

We maintain comprehensive testing facilities across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network ensures that quality genetic testing is accessible regardless of your location.

Pre-Test Instructions

Sickle Cell Disease Mutation Screening requires a Doctor’s prescription for most cases. However, prescription requirements do not apply for surgical clearance, pregnancy-related testing, or international travel preparation. Please bring any relevant medical documentation to your appointment.

Take Control of Your Genetic Health Today

Don’t wait to gain crucial insights into your genetic health. Our Sickle Cell Disease Mutation Screening provides the definitive answers you need for informed healthcare decisions. With rapid 3-4 day turnaround and expert genetic counseling support, you’ll receive comprehensive care from start to finish.

Book your Sickle Cell Disease Mutation Screening today by calling +1(267) 388-9828 or schedule your appointment online. Take the first step toward understanding your genetic health with confidence and clarity.